PERSPECTA

News from every angle

Back to headlines

Fractyl Health Details 2026 De Novo Submission and Q4 Revita Data Plans

Fractyl Health has outlined its plans for a 2026 De Novo submission, with pivotal data for its Revita treatment anticipated to be released in early Q4.

24 Mar, 22:55 — 24 Mar, 22:55
PostShare

Sources

Showing 1 of 1 sources